treatment of cancer articles & resources on Made-in-China.com

Bosch Kept Its FXS Combi Under Wraps Until Interpack

May 12, 2014

Bosch kept its FXS Combi under wraps until interpack. This machine, Bosch gauged, deserved to be unveiled at the world's leading packaging innovations exhibition. Depending on output and container, the machine with two or five positions ...

Tags: Bosch, Pharmaceutical Packaging Equipment, Industrial Equipment, Tools

CEL-SCI Corporation Has Received Approval From The Medicines and Medical Device Agency

Jan 26, 2014

CEL-SCI Corporation has received approval from the Medicines and Medical Device Agency of Serbia to begin enrollment of subjects in its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment ...

Tags: CEL-SCI, SOC, Multikine, Cancer

Patients with Advanced Pancreatic Cancer May Live a Little Longer

Jan 16, 2014

Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...

Tags: a

Patients with Advanced Pancreatic Cancer May Live a Little Longer

Jan 16, 2014

Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...

Tags: advanced pancreatic cancer, two therapeutic vaccines

Roche and Molecular Partners Have Entered Into a Research Collaboration

Dec 9, 2013

Roche and Molecular Partners have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular' DARPin biologics conjugated to toxic agents ...

Tags: Roche, Molecular Partners

Agalimmune Has Been Created to Develop Innovative Immunotherapeutics

Nov 29, 2013

Agalimmune, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours. The new company has been founded by an investment group comprising Loxbridge ...

Tags: solid tumours, cancer treatment

Bioinvent International Has Secured a US Patent for Its Antibody,Discovery Technology

Nov 14, 2013

BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously. ...

Tags: Antibody Screening Technology, BioInvent

Nuvilex Has Acquired The Exclusive Worldwide Rights

Nov 12, 2013

Nuvilex, an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, has acquired the exclusive worldwide rights to use the cellulose-based live-cell encapsulation technology for the ...

Tags: Nuvilex, Live-Cell Encapsulation Technology, biotechnology, cell, gene

IceCure Announced First Breast Cancer Patient Using The Icesense3 Cryoablation System

Nov 12, 2013

IceCure Medical has announced that the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California, treated its first breast cancer patient using the IceSense3 cryoablation system in a pilot study evaluating ...

Tags: IceCure, breast cancer, IceSense3 cryoablation system

Boehringer Ingelheim Has Submitted a Marketing Authorisation Application to EMA

Oct 16, 2013

Boehringer Ingelheim has submitted a marketing authorisation application to the European Medicines Agency (EMA) for the approval of its oral triple angiokinase inhibitor nintedanib. Nintedanib to be used in combination with docetaxel is ...

Tags: Boehringer Ingelheim, Lung Cancer

CRT Has Signed a Multi-Project Alliance Agreement with TEVA

Sep 18, 2013

Cancer Research Technology (CRT), Cancer Research UK's technology development arm, has signed a multi-project alliance agreement with Teva Pharmaceutical Industries (TEVA) to research and develop new cancer drugs, which will help in ...

Tags: Cancer Research Technology, Medicine

Regen Signed a Licensing Deal with Benitec Biopharma for DdRNAi Gene Silencing Technology

Aug 13, 2013

Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific, has signed a licensing deal with Benitec Biopharma for ddRNAi gene silencing technology to develop vaccines. Regen will apply ddRNAi to silence indoleamine 2,3 -- ...

Tags: Regen BioPharma, Medicine

Switzerland-Based Celgene International SáRl Has Received Approval From The EC

Jun 20, 2013

Switzerland-based Celgene International Sárl has received approval from the European Commission (EC) to allow its Revlimid drug to treat patients with transfusion-dependent anaemia. While other remedial options could not yield ...

Tags: Myelodysplastic Syndromes, Medicine

PharmaMar Has Selected Medidata Clinical Cloud Platform for Marine-Based Oncology Drugs

Mar 20, 2013

Spanish biopharmaceutical company PharmaMar has selected Medidata Solutions' Medidata Clinical Cloud platform to accelerate clinical trials for marine-based oncology drugs. A member of the Zeltia Group and a developer of antitumor drugs ...

Tags: PharmaMar, Medidata Clinical, biopharmaceutical

Prostate Cancer Test Study Results Are Presented by Mdxhealth

Feb 21, 2013

MDxHealth has presented results from two studies of its DNA methylation-based assay at the ASCO Genitourinary Cancers Symposium 2013, held at Orlando, Florida, US from 14 - 16 February 2013. The epigenetic assay, ConfirmMDx for Prostate ...

Tags: MDxHealth, Prostate Cancer, clinical pathologist

treatment of cancer

Related Products